Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 319481 - 319500 out of 495987 entries
Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
---|---|---|---|---|---|---|---|---|
Luxembourg | (L01XC03) trastuzumab | HERCEPTIN PDRE SOLCC.SOL.PERF. 150 mg 1*1 flacon | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | n/a |
Luxembourg | (L01XC06) cetuximab | ERBITUX SOL.PERF. 5 mg / 1 mL 1*1 flacon (verre) 100 mL | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Head and Neck Neoplasms; Colorectal Neoplasms | n/a |
Luxembourg | (L01XC06) cetuximab | ERBITUX SOL.PERF. 5 mg / 1 mL 1*1 flacon (verre) 20 mL | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Head and Neck Neoplasms; Colorectal Neoplasms | n/a |
Luxembourg | (L01XC12) brentuximab vedotin | Adcetris PSV.SOL.PERF. 5 mg / 1 mL 1*1 fl.verre | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin; Hodgkin Disease | n/a |
Luxembourg | (L01XC12) brentuximab vedotin | Adcetris-50 mg (Abacus Medicine) PSV.SOL.PERF. 5 mg / 1 mL 1*1 fl.verre | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin; Hodgkin Disease | n/a |
Luxembourg | (L01XC13) pertuzumab | Perjeta (Abacus Medicine) SOLCC.PERF. 30 mg / 1 mL 1*1 flacon verre | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | n/a |
Luxembourg | (L01XC13) pertuzumab | Perjeta-420mg SOLCC.PERF. 30 mg / 1 mL 1*1 flacon verre | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | n/a |
Luxembourg | (L01XC15) obinutuzumab | Gazyvaro (Abacus Medicine) SOLCC.PERF. 1000 mg / 40 mL 1*1 flacon 40 mL | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | n/a |
Luxembourg | (L01XC15) obinutuzumab | Gazyvaro SOLCC.PERF. 1000 mg / 40 mL 1*1 flacon 40 mL | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | n/a |
Luxembourg | (L01XC23) elotuzumab | Empliciti (Abacus Medicine) PDRE SOLCC.PERF. 300 mg 1*1 flacon (verre) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | n/a |
Luxembourg | (L01XC23) elotuzumab | Empliciti (Abacus Medicine) PDRE SOLCC.PERF. 400 mg 1*1 flacon (verre) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | n/a |
Luxembourg | (L01XC24) daratumumab | Darzalex (Abacus Medicine) SOLCC.PERF. 20 mg / 1 mL 1*1 flacon verre 20 ml | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | n/a |
Luxembourg | (L01XC24) daratumumab | Darzalex SOLCC.PERF. 20 mg / 1 mL 1*1 flacon verre 20 ml | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | n/a |
Luxembourg | (L01XC24) daratumumab | Darzalex SOLCC.PERF. 20 mg / 1 mL 1*1 flacon verre 5 ml | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | n/a |
Luxembourg | (L01XC26) inotuzumab ozogamicin | Besponsa PDRE SOLCC.SOL.PERF. 1 mg 1*1 flacon (verre) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | n/a |
Luxembourg | (L01XC31) avelumab | Bavencio (Abacus Medicine) SOLCC.PERF. 20 mg / 1 mL 1*1 flacon 10 mL | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Neuroendocrine Tumors | n/a |
Luxembourg | (L01XC38) isatuximab | SARCLISA SOLCC.PERF. 20 mg / 1 mL 1*1 flacon 25 mL | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | n/a |
Luxembourg | (L01XC38) isatuximab | SARCLISA SOLCC.PERF. 20 mg / 1 mL 1*1 flacon 5 mL | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | n/a |
Luxembourg | (L01XC39) belantamab mafodotin | BLENREP PDRE SOLCC.PERF. 100 mg 1*1 flacon | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | n/a |
Luxembourg | (L01XD04) aminolevulinic acid | Ameluz GEL 78 mg / 1 g 1*1 tube 2 g | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Keratosis, Actinic; Carcinoma, Basal Cell | n/a |